Shield Therapeutics plc (STX.L) LSE

10.75

-0.15(-1.38%)

Updated at December 24 12:29PM

Currency In GBp

Valuation

Market Cap24.44M
Enterprise Value39.89M
P/E Ratio-6.82
PEG Ratio-0.07
Price/Sales Ratio3.56
Price/Book Ratio-7.54
Enterprise/Revenue4.07
Enterprise/EBITDA-13.13

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.51
Operating Margin-0.35

Management Effectiveness

Return On Assets-0.26
Return On Equity2.06

Income Statement

Revenue25.18M
Revenue/Share0.03
Gross Profit10.57M
EBITDA-16.58M
Net Income-21.27M
Diluted EPS-0.02

Balance Sheet

Total Cash10.81M
Total Cash/Share0.01
Total Debt27.05M
Total Debt/Equity-1.82
Current Ratio0.83
Book Value Per Share-0.01

Price History

52-Week Change298.15
52-Week High12.5
52-Week Low2.1
Moving Average 50 Days8.52
Moving Average 200 Days5.38

Statistics

Average Volume3.13M
Shares Outstanding1.06B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1029:1000
Last Split DateDecember 16, 2022